Syros Pharmaceuticals Correlations

SYRS Stock

USD 0.25 0.01 4.23%

The current 90-days correlation between Syros Pharmaceuticals and Surrozen is 0.22 (i.e., Modest diversification). The correlation of Syros Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Syros Pharmaceuticals Correlation With Market

Significant diversification

The correlation between Syros Pharmaceuticals and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Syros Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Syros Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Syros Stock please use our How to Invest in Syros Pharmaceuticals guide.

Moving together with Syros Stock

0.81	DNTH	Dianthus Therapeutics	Pair Corr
0.71	DRRX	Durect	Pair Corr
0.75	VIGL	Vigil Neuroscience	Pair Corr
0.65	VIRX	Viracta Therapeutics	Pair Corr
0.8	VKTX	Viking Therapeutics Potential Growth	Pair Corr
0.64	VTGN	VistaGen Therapeutics	Pair Corr

Moving against Syros Stock

0.64	VCEL	Vericel Corp Ord	Pair Corr
0.55	VANI	Vivani Medical	Pair Corr
0.51	VCYT	Veracyte	Pair Corr
0.47	DRTS	Alpha Tau Medical Trending	Pair Corr
0.31	VERA	Vera Therapeutics	Pair Corr
0.72	DYAI	Dyadic International	Pair Corr
0.68	VTVT	vTv Therapeutics	Pair Corr
0.6	VTRS	Viatris	Pair Corr
0.36	VSTM	Verastem Trending	Pair Corr
0.35	DVAX	Dynavax Technologies	Pair Corr
0.35	VNDA	Vanda Pharmaceuticals	Pair Corr

Related Correlations Analysis

	SRZN	BOLT	LRMR	KROS	KZR	IDYA	SNDX	XNCR	RGNX	CRNX
SRZN		0.37	0.04	0.23	0.45	-0.33	0.23	-0.08	-0.61	0.09	SRZN
BOLT	0.37		0.5	0.13	0.11	0.41	0.67	-0.45	-0.01	0.11	BOLT
LRMR	0.04	0.5		0.37	0.04	0.32	0.6	-0.19	0.13	0.41	LRMR
KROS	0.23	0.13	0.37		0.56	-0.44	0.27	0.41	-0.34	0.6	KROS
KZR	0.45	0.11	0.04	0.56		-0.66	0.01	0.36	-0.7	0.55	KZR
IDYA	-0.33	0.41	0.32	-0.44	-0.66		0.48	-0.7	0.8	-0.46	IDYA
SNDX	0.23	0.67	0.6	0.27	0.01	0.48		-0.51	0.2	0.07	SNDX
XNCR	-0.08	-0.45	-0.19	0.41	0.36	-0.7	-0.51		-0.3	0.62	XNCR
RGNX	-0.61	-0.01	0.13	-0.34	-0.7	0.8	0.2	-0.3		-0.33	RGNX
CRNX	0.09	0.11	0.41	0.6	0.55	-0.46	0.07	0.62	-0.33		CRNX
	SRZN	BOLT	LRMR	KROS	KZR	IDYA	SNDX	XNCR	RGNX	CRNX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RGNX	+ 0.8	IDYA
SNDX	+ 0.67	BOLT
CRNX	+ 0.62	XNCR
SNDX	+ 0.6	LRMR
CRNX	+ 0.6	KROS
KZR	+ 0.56	KROS

High negative correlations

XNCR	- 0.7	IDYA
RGNX	- 0.7	KZR
IDYA	- 0.66	KZR
RGNX	- 0.61	SRZN
XNCR	- 0.51	SNDX
CRNX	- 0.46	IDYA

Risk-Adjusted Indicators

There is a big difference between Syros Stock performing well and Syros Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Syros Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SRZN	5.15	0.52	0.06	(0.53)	4.91	(6.73)	16.88	(7.91)	33.59
BOLT	1.80	(0.14)	0.00	(0.54)	0.00	0.00	4.84	(4.48)	14.96
LRMR	4.21	(0.47)	0.00	(0.13)	0.00	0.00	10.87	(9.55)	26.71
KROS	2.13	0.21	0.10	0.27	2.19	(2.30)	4.39	(4.31)	16.94
KZR	2.92	0.36	0.12	0.45	2.71	(4.04)	4.93	(3.88)	51.13
IDYA	2.24	(0.69)	0.00	(0.32)	0.00	0.00	4.15	(5.09)	15.21
SNDX	2.29	(0.49)	0.00	(0.08)	0.00	0.00	4.02	(4.33)	34.00
XNCR	2.20	0.48	0.33	0.35	1.35	(3.01)	4.84	(3.14)	26.75
RGNX	3.31	(0.42)	0.00	(0.09)	0.00	0.00	5.72	(7.20)	32.22
CRNX	1.67	0.04	0.01	0.16	2.44	(1.56)	3.67	(3.45)	16.75

Syros Pharmaceuticals Corporate Management

James MD	Founder	Profile
Lisa Roberts	Vice Resources	Profile
JD Esq	Chief Development	Profile
Eric Olson	Chief Scientific Officer	Profile
Jason Haas	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC